| Schedule of Share-based Compensation Expenses and Related Tax Benefits Recognized |
The following table summarizes share-based compensation expense and total income tax benefit recognized for the three and nine months ended December 31, 2025 and 2024 (in thousands): | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended December 31, | | Nine Months Ended December 31, | | | | 2025 | | 2024 | | 2025 | | 2024 | | Cost of goods sold | | $ | 2,636 | | | $ | 2,173 | | | $ | 8,375 | | | $ | 8,673 | | | Marketing and selling | | 5,911 | | | 11,813 | | | 31,982 | | | 34,133 | | | Research and development | | 5,395 | | | 5,043 | | | 17,412 | | | 15,849 | | | General and administrative | | 9,493 | | | 7,164 | | | 28,806 | | | 17,412 | | | | | | | | | | | | Total share-based compensation expense | | 23,435 | | | 26,193 | | | 86,575 | | | 76,067 | | | Income tax benefit | | (4,699) | | | (4,523) | | | (15,620) | | | (16,901) | | | Total share-based compensation expense, net of income tax benefit | | $ | 18,736 | | | $ | 21,670 | | | $ | 70,955 | | | $ | 59,166 | |
|